Otros idiomas Titan Pharmaceuticals, Inc.

Acciones

TTNP

US8883147055

Tiempo real estimado Cboe BZX Otros sitios de cotización 15:30:05 13/05/2024			Varia. Cinco días.	Varia. 1 de enero.
6,8 ^USD	-1,45 %		+0,29 %	-16,36 %

01/04	Titan Pharmaceuticals, Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI
26/01	Titan Pharmaceuticals vuelve a cumplir la norma de cotización del Nasdaq	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Titan Pharmaceuticals : Non-Reliance on Previously Issued Financial Report - Form 8-K	01/04
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Titan Pharmaceuticals : Private Placement - Form 8-K	21/03
Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule	26/01
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria	25/01
Titan Pharmaceuticals, Inc. Announces Resignation of Brian Crowley as Senior Vice President, Finance and Administration, Effective February 2, 2024	18/01
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - December 28, 2023	29/12
Titan Pharmaceuticals to Implement 1-for-20 Reverse Stock Split	29/12
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio	28/12
Titan Pharmaceuticals: Q3 Earnings Snapshot	15/11
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Titan Pharmaceuticals, Inc. Announces Board Changes	16/10/23
Titan Pharmaceuticals Appoints New Chairman of the Board	16/10/23
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors	16/10/23
Titan Pharmaceuticals, Inc. Announces Board Resignations	19/09/23
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock	18/09/23
Titan Pharmaceuticals, Inc. announced that it expects to receive $9.5 million in funding from Sire Group Ltd	13/09/23
TITAN PHARMACEUTICALS : UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION - Form 8-K	08/09/23
Fedson, Inc. completed the acquisition of Certain ProNeura Assets of Titan Pharmaceuticals, Inc..	01/09/23
Titan Pharmaceuticals: Q2 Earnings Snapshot	15/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Titan Pharmaceuticals, Inc.

Acciones

TTNP

US8883147055

Otros idiomas

Filtros